Five Prime Therapeutics, Inc. FPRX was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $3.83 – $5.46 in the past one-month time frame, witnessed a sharp increase on Friday. The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Five Prime. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.Five Prime currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive. Five Prime Therapeutics, Inc. Price Five Prime Therapeutics, Inc. price | Five Prime Therapeutics, Inc. QuoteInvestors interested in the Medical - Biomedical and Genetics industry may consider QIAGEN N.V. QGEN, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Zacks’ 2020 Election Stock ReportIn addition to the companies you learned about above, we invite you to learn more about profiting from the upcoming presidential election. Trillions of dollars will shift into new market sectors after the votes are tallied, and investors could see significant gains. This report reveals specific stocks that could soar: 6 if Trump wins, 6 if Biden wins.Check out the 2020 Election Stock Report >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report QIAGEN N.V. (QGEN): Free Stock Analysis Report Five Prime Therapeutics, Inc. (FPRX): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research